Availability of Drugs and Resistance Testing for BPaLM Regimen for Rifampicin-Resistant Tuberculosis in Europe
Clinical Microbiology and Infection（2024）
Key words
Editor: E. Bottieau,BPaLM,MDR/RR-TB,XDR-TB,TBNET,Access,DR-TB,Implementation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined